{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:48:00Z","timestamp":1788526080675,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2011,3,20]],"date-time":"2011-03-20T00:00:00Z","timestamp":1300579200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1007\/s00415-011-5998-9","type":"journal-article","created":{"date-parts":[[2011,3,19]],"date-time":"2011-03-19T12:14:28Z","timestamp":1300536868000},"page":"1670-1675","source":"Crossref","is-referenced-by-count":22,"title":["Botulinum toxin treatment in neurological practice: how much does it really cost? A prospective cost-effectiveness study"],"prefix":"10.1007","volume":"258","author":[{"given":"Pierre","family":"Burbaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Ducerf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Cugy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Dubos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Guehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Dehail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Cugy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Lagueny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Alain","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,20]]},"reference":[{"key":"5998_CR1","first-page":"71","volume":"11","author":"R Balkrishnan","year":"2002","unstructured":"Balkrishnan R, Camacho FT, Smith BP, Shilt JS, Jacks LK, Koman LA, Rascati KL, Mooney JF 3rd (2002) Cost impact of botulinum toxin use in Medicaid-enrolled children with cerebral palsy. J South Orthop Assoc 11:71\u201379","journal-title":"J South Orthop Assoc"},{"key":"5998_CR2","doi-asserted-by":"crossref","unstructured":"Bodenez C, Bernat I, Willer JC, Barre P, Lamas G, Tankere F (2010) Facial nerve decompression for idiopathic Bell\u2019s palsy: report of 13 cases and literature review. J Laryngol Otol 124:272\u2013278","DOI":"10.1017\/S0022215109991265"},{"key":"5998_CR3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00002826-200007000-00006","volume":"23","author":"C Brefel-Courbon","year":"2000","unstructured":"Brefel-Courbon C, Simonetta-Moreau M, More C, Rascol O, Clanet M, Montastruc JL, Lapeyre-Mestre M (2000) A pharmacoeconomic evaluation of botulinum toxin in the treatment of spasmodic torticollis. Clin Neuropharmacol 23:203\u2013207","journal-title":"Clin Neuropharmacol"},{"key":"5998_CR4","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/01.phm.0000223216.50068.bc","volume":"85","author":"M Cioni","year":"2006","unstructured":"Cioni M, Esquenazi A, Hirai B (2006) Effects of botulinum toxin-A on gait velocity, step length, and base of support of patients with dynamic equinovarus foot. Am J Phys Med Rehabil 85:600\u2013606","journal-title":"Am J Phys Med Rehabil"},{"key":"5998_CR5","unstructured":"Costa J, Espirito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P, Sampaio C (2005) Botulinum toxin type A therapy for blepharospasm. Cochrane Database Syst Rev:CD004900"},{"key":"5998_CR6","doi-asserted-by":"crossref","unstructured":"Costa J, Espirito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P, Sampaio C (2005) Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev:CD003633","DOI":"10.1002\/14651858.CD003633.pub2"},{"key":"5998_CR7","doi-asserted-by":"crossref","unstructured":"Costa J, Espirito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P, Sampaio C (2005) Botulinum toxin type A therapy for hemifacial spasm. Cochrane Database Syst Rev:CD004899","DOI":"10.1002\/14651858.CD004899.pub2"},{"key":"5998_CR8","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00019053-199712060-00009","volume":"12","author":"RC Dodel","year":"1997","unstructured":"Dodel RC, Kirchner A, Koehne-Volland R, Kunig G, Ceballos-Baumann A, Naumann M, Brashear A, Richter HP, Szucs TD, Oertel WH (1997) Costs of treating dystonias and hemifacial spasm with botulinum toxin A. Pharmacoeconomics 12:695\u2013706","journal-title":"Pharmacoeconomics"},{"key":"5998_CR9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2165\/00019053-199712060-00007","volume":"12","author":"CM Gudex","year":"1997","unstructured":"Gudex CM, Hawthorne MR, Butler AG, Duffey PO (1997) Measuring patient benefit from botulinum toxin in the treatment of dystonia. Feasibility of cost-utility analysis. Pharmacoeconomics 12:675\u2013684","journal-title":"Pharmacoeconomics"},{"key":"5998_CR10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1212\/01.wnl.0000252932.71306.89","volume":"68","author":"SW Hung","year":"2007","unstructured":"Hung SW, Hamani C, Lozano AM, Poon YY, Piboolnurak P, Miyasaki JM, Lang AE, Dostrovsky JO, Hutchison WD, Moro E (2007) Long-term outcome of bilateral pallidal deep brain stimulation for primary cervical dystonia. Neurology 68:457\u2013459","journal-title":"Neurology"},{"key":"5998_CR11","doi-asserted-by":"crossref","unstructured":"Kaji R, Osako Y, Suyama K, Maeda T, Uechi Y, Iwasaki M (2010) Botulinum toxin type A in post-stroke upper limb spasticity. Curr Med Res Opin 26:1983\u20131992","DOI":"10.1185\/03007995.2010.497103"},{"key":"5998_CR12","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/brain\/awm229","volume":"130","author":"ZH Kiss","year":"2007","unstructured":"Kiss ZH, Doig-Beyaert K, Eliasziw M, Tsui J, Haffenden A, Suchowersky O (2007) The Canadian multicentre study of deep brain stimulation for cervical dystonia. Brain 130:2879\u20132886","journal-title":"Brain"},{"key":"5998_CR13","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1590\/S0004-27492006000500016","volume":"69","author":"CG Lasalvia","year":"2006","unstructured":"Lasalvia CG, Pereira Lde S, da Cunha MC, Kitadai SP (2006) Costs and efficacy of type A botulinum toxin for the treatment of essential blepharospasm and hemifacial spasm. Arq Bras Oftalmol 69:701\u2013705","journal-title":"Arq Bras Oftalmol"},{"key":"5998_CR14","doi-asserted-by":"crossref","first-page":"442","DOI":"10.18553\/jmcp.2008.14.5.442","volume":"14","author":"MP Mitchell","year":"2008","unstructured":"Mitchell MP, Schaecher K, Cannon HE, Speckman M (2008) Humanistic, utilization, and cost outcomes associated with the use of botulinum toxin for treatment of refractory migraine headaches in a managed care organization. J Manag Care Pharm 14:442\u2013450","journal-title":"J Manag Care Pharm"},{"key":"5998_CR15","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1468-1331.2008.02520.x","volume":"16","author":"E Moro","year":"2009","unstructured":"Moro E, Piboolnurak P, Arenovich T, Hung SW, Poon YY, Lozano AM (2009) Pallidal stimulation in cervical dystonia: clinical implications of acute changes in stimulation parameters. Eur J Neurol 16:506\u2013512","journal-title":"Eur J Neurol"},{"key":"5998_CR16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1745-6215-9-59","volume":"9","author":"H Rodgers","year":"2008","unstructured":"Rodgers H, Shaw L, Price C, van Wijck F, Barnes M, Graham L, Ford G, Shackley P, Steen N (2008) Study design and methods of the BoTULS trial: a randomised controlled trial to evaluate the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A. Trials 9:59","journal-title":"Trials"},{"key":"5998_CR17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10198-004-0224-7","volume":"5","author":"FJ Ruiz","year":"2004","unstructured":"Ruiz FJ, Guest JF, Lehmann A, Davie AM, Guttler K, Schluter O, Dreiss G (2004) Costs and consequences of botulinum toxin type A use. Management of children with cerebral palsy in Germany. Eur J Health Econ 5:227\u2013235","journal-title":"Eur J Health Econ"},{"key":"5998_CR18","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1016\/j.juro.2009.08.031","volume":"182","author":"NY Siddiqui","year":"2009","unstructured":"Siddiqui NY, Amundsen CL, Visco AG, Myers ER, Wu JM (2009) Cost-effectiveness of sacral neuromodulation versus intravesical botulinum A toxin for treatment of refractory urge incontinence. J Urol 182:2799\u20132804","journal-title":"J Urol"},{"key":"5998_CR19","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1212\/01.wnl.0000311389.26145.95","volume":"70","author":"DM Simpson","year":"2008","unstructured":"Simpson DM, Blitzer A, Brashear A, Comella C, Dubinsky R, Hallett M, Jankovic J, Karp B, Ludlow CL, Miyasaki JM, Naumann M, So Y (2008) Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 70:1699\u20131706","journal-title":"Neurology"},{"key":"5998_CR20","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.neuchi.2009.02.012","volume":"55","author":"M Sindou","year":"2009","unstructured":"Sindou M, Keravel Y (2009) Neurosurgical treatment of primary hemifacial spasm with microvascular decompression. Neurochirurgie 55:236\u2013247","journal-title":"Neurochirurgie"},{"key":"5998_CR21","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/16501970510027312","volume":"37","author":"A Ward","year":"2005","unstructured":"Ward A, Roberts G, Warner J, Gillard S (2005) Cost-effectiveness of botulinum toxin type a in the treatment of post-stroke spasticity. J Rehabil Med 37:252\u2013257","journal-title":"J Rehabil Med"},{"key":"5998_CR22","first-page":"575","volume":"47","author":"AP Yelnik","year":"2004","unstructured":"Yelnik AP (2004) Pharmacology and upper limb poststroke spasticity: a review. International Society of Prosthetics and Orthotics. Ann Readapt Med Phys 47:575\u2013589","journal-title":"Ann Readapt Med Phys"},{"key":"5998_CR23","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.rehab.2009.09.005","volume":"52","author":"AP Yelnik","year":"2009","unstructured":"Yelnik AP, Simon O, Bensmail D, Chaleat-Valayer E, Decq P, Dehail P, Quentin V, Marque P, Parratte B, Pellas F, Rousseaux M, Trocello JM, Uzzan M, Dumarcet N (2009) Drug treatments for spasticity. Ann Phys Rehabil Med 52:746\u2013756","journal-title":"Ann Phys Rehabil Med"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-011-5998-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-011-5998-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-011-5998-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T14:03:36Z","timestamp":1637417016000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-011-5998-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,20]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["5998"],"URL":"https:\/\/doi.org\/10.1007\/s00415-011-5998-9","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,20]]}}}